We are live on ! Find out more
PASG icon

Passage Bio

45 hedge funds and large institutions have $462M invested in Passage Bio in 2020 Q1 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3.34% more ownership

Funds ownership: 0%3.34% (+3.3%)

Holders
45
Holders Change
+45
Holders Change %
% of All Funds
0.99%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.07%
New
45
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AI
26
Atom Investors
Texas
$2.36M +$2.35M +7,500 New
Wellington Management Group
27
Wellington Management Group
Massachusetts
$2.02M +$2M +6,401 New
Goldman Sachs
28
Goldman Sachs
New York
$1.94M +$1.93M +6,160 New
ACH
29
ArrowMark Colorado Holdings
Colorado
$977K +$970K +3,100 New
MWNA
30
Marshall Wace North America
New York
$965K +$958K +3,062 New
CCM
31
CAAS Capital Management
New York
$788K +$782K +2,500 New
Federated Hermes
32
Federated Hermes
Pennsylvania
$630K +$626K +2,000 New
CCM
33
Cinctive Capital Management
New York
$338K +$336K +1,074 New
Norges Bank
34
Norges Bank
Norway
$315K +$313K +1,000 New
HSBC Holdings
35
HSBC Holdings
United Kingdom
$228K +$227K +725 New
Citadel Advisors
36
Citadel Advisors
Florida
$200K +$199K +637 New
Blackstone Inc
37
Blackstone Inc
New York
$189K +$188K +600 New
Vanguard Group
38
Vanguard Group
Pennsylvania
$181K +$179K +572 New
TD Asset Management
39
TD Asset Management
Ontario, Canada
$165K +$164K +525 New
MS
40
Maven Securities
Jersey
$164K +$163K +520 New
Bank of America
41
Bank of America
North Carolina
$125K +$124K +397 New
PCM
42
Pinz Capital Management
New York
$67K +$66.6K +213 New
Citigroup
43
Citigroup
New York
$18K +$17.5K +56 New
NC
44
NewSquare Capital
Pennsylvania
$16K +$15.6K +50 New
TRCT
45
Tower Research Capital (TRC)
New York
$2K +$2.19K +7 New

PASG Hedge Fund Activity: Q1 2020 in Review

45 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q1 2020, worth a combined $462M.

Buyers outnumbered sellers: 45 funds opened new PASG positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $109M.

  • 45 institutional investors held Passage Bio (PASG) as of Q1 2020, up from 0 in Q4 2019.
  • Funds reported $462M of Passage Bio stock for Q1 2020.
  • 45 funds opened new Passage Bio positions in Q1 2020 and 0 closed out, a net change of +45 holders.
  • The largest Passage Bio buyer in Q1 2020 was OrbiMed, an estimated $109M added.

Based on aggregated 13F filings for Q1 2020.